PMID: 11318801Apr 25, 2001Paper

Evaluation of a global screening assay for the investigation of the protein C anticoagulant pathway

Clinical and Laboratory Haematology
J E RimmerM Makris

Abstract

We have evaluated a global screening test for the protein C pathway, the 'ProC Global' (Dade Behring Ltd, Milton Keynes, UK). Patient groups tested included inherited protein C or S deficient and inherited/acquired activated protein C resistance. Results showed that protein C deficiencies and activated protein C resistance could be successfully detected with this test whereas deficiencies of protein S were less readily distinguished from the normal population. The ProC Global was unreliable in patients with antiphospholipid antibodies, raised plasma factor VIII:C and in those receiving oral anticoagulant therapy.

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
D GemmatiG L Scapoli
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
C GardinerS J Machin
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
J C QuincampoixP Toulon
Molecular Genetics and Metabolism
C A Spek, P H Reitsma
© 2021 Meta ULC. All rights reserved